Scandion Oncology A/S
|Category:||Clinical Stage Biotech Company|
|Date:||April 25, 2023|
|Time:||12:45 – 13:00|
|Speaker:||Mads Aaboe Jensen, VP, Business development & Innovation|
Scandion Oncology discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options. We are world leaders in reverting cancer’s resistance against treatment, thus making the treatment work better and longer thereby potentially prolonging and improving the lives of patients who would otherwise have a high risk of dying from their cancer.